Practice Management News

The Trump administration has named Georgia health commissioner Brenda Fitzgerald, MD, to be the next CDC director.

Although most clinicians multitask while using electronic health records, which increases the risk for communication and timeliness errors, transitions to silent EHR use can have unclear ramifications, according to a research letter published in JAMA Internal Medicine.

New data showed a link between significant rises in generic drug prices and decreased market competition, according to a study published in Annals of Internal Medicine.

Running a practice without looking at financial reports is like diagnosing a patient without checking blood pressure or ordering blood work: Chances are, you are going to miss something important. Truth is, it is impossible to identify or make sound business decisions without first looking at some data.

President Donald J. Trump has nominated Jerome M. Adams, MD, MPH, who has advocated for needle exchange programs, to be the next U.S. Surgeon General.

An AMA survey revealed that 51% of physicians who are involved in practice decision-making are only somewhat knowledgeable about the Medicare Access and CHIP Reauthorization Act of 2015 and the Quality Payment Program.

AMA and ACP’s presidents are commending the members of the U.S. House Representatives for passing House Resolution 1215, also known as the Protecting Access to Care Act.

At a meeting held by HHS Secretary Tom Price, MD, to examine the impact of government requirements on the clinician-patient relationship, ACP emphasized the importance of reducing excessive administrative tasks, according to a press release.

The FDA has released the details of its Orphan Drug Modernization Plan, developed to eliminate the existing orphan drug request backlog and create a system for timely response deadlines for all future requests. This plan will be one of several efforts as part of the agency’s encompassing Medical Innovation Development Plan.

From 2006 to 2012, researchers observed an increased use of palliative care in patients with end-stage liver disease, according to a recently published study. However, they also observed socioeconomic and ethnic barriers to access.